Trials / Terminated
TerminatedNCT02931266
PASS MIS® Post-market Clinical Follow-up
Evaluation of the Efficacy and Safety of the PASS MIS® System in the Treatment of Spinal Thoracolumbar Fractures
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 5 (actual)
- Sponsor
- Medicrea International · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective, multicenter non comparative and observational study (post-market clinical follow-up).
Detailed description
Patients operated with PASS MIS® manufactured by MEDICREA® INTERNATIONAL between July 2016 and July 2017. The inclusion period will be 12 months and the follow-up 24 months
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PASS MIS® | Posterior mini-invasive osteosynthesis |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2018-01-01
- Completion
- 2018-01-01
- First posted
- 2016-10-13
- Last updated
- 2023-05-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02931266. Inclusion in this directory is not an endorsement.